Intuitive Surgical - ISRG Stock Forecast, Price & News

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Citigroup lowered their target price on Intuitive Surgical from $360.00 to $305.00 in a report on Tuesday, May 17th. BTIG Research cut their target price on shares of Intuitive Surgical from $355.00 to $247.00 and set a "buy" rating on the stock in a research note on Monday, July 18th. Evercore ISI decreased their price target on shares of Intuitive Surgical from $210.00 to $175.00 in a research note on Friday, July 22nd. Wells Fargo & Company cut their price objective on shares of Intuitive Surgical to $265.00 in a research report on Friday, July 22nd. Finally, TheStreet lowered Intuitive Surgical from a "b-" rating to a "c+" rating in a research report on Thursday, May 19th. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $273.23.

Intuitive Surgical Trading Up 0.8 %

Shares of ISRG traded up $1.96 during trading hours on Monday, reaching $242.28. 31,298 shares of the stock traded hands, compared to its average volume of 2,150,588. Intuitive Surgical has a 52 week low of $186.83 and a 52 week high of $369.69. The company has a market cap of $86.52 billion, a price-to-earnings ratio of 61.15, a PEG ratio of 6.70 and a beta of 1.29. The stock has a fifty day simple moving average of $212.55 and a 200 day simple moving average of $249.25.

Intuitive Surgical (NASDAQ:ISRG - Get Rating) last posted its earnings results on Thursday, July 21st. The medical equipment provider reported $1.14 EPS for the quarter, topping the consensus estimate of $1.01 by $0.13. Intuitive Surgical had a net margin of 24.05% and a return on equity of 12.04%. During the same quarter in the previous year, the company posted $1.42 EPS. Analysts predict that Intuitive Surgical will post 3.76 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Amal M. Johnson sold 6,375 shares of the firm's stock in a transaction on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now directly owns 11,224 shares of the company's stock, valued at approximately $2,671,760.96. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Intuitive Surgical news, EVP Myriam Curet sold 9,000 shares of the stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total transaction of $2,025,000.00. Following the completion of the transaction, the executive vice president now directly owns 217 shares of the company's stock, valued at $48,825. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Amal M. Johnson sold 6,375 shares of the business's stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total value of $1,517,505.00. Following the completion of the sale, the director now owns 11,224 shares in the company, valued at $2,671,760.96. The disclosure for this sale can be found here. Over the last three months, insiders have sold 94,787 shares of company stock worth $20,719,321. 0.90% of the stock is owned by company insiders.